Cyclosporin A is an immunosuppressive agent known to cause hirsutism. The mechanisms of action that cause hirsutism have not been fully elucidated, however. We have previously reported that several selective protein kinase C inhibitors promote the growth of murine hair epithelial cells and stimulate anagen induction. In this paper, we report on an investigation of the mechanisms of action of hairgrowing activity possessed by cyclosporin A from the viewpoint of whether it promotes hair epithelial cell growth or whether it modulates the expression or translocation of protein kinase C isozymes in hair epithelial cells. Our results indicate that cyclosporin A (over a wide dosage range of 1±1000 ng per ml) stimulates cultured murine hair epithelial cell growth to about 150%±160% relative to controls. We also observed growth-promoting effects on murine epidermal keratinocytes (about 140%) at the dose range of 1±100 ng per ml. At high dose ranges above 3 mg per ml, the growth of both cells was inhibited. On the other hand, we found that cyclosporin A reduces the overall expression of protein kinase C a, bI, and bII in cultured murine hair epithelial cells, and reduces the levels of protein kinase C a, bI, bII, and h in the particulate fraction from cultured murine hair epithelial cells. From these results, we speculate that the hair-growing activity of cyclosporin A is at least partially attributable to its growth-promoting in¯uence on hair epithelial cells sequential to its downregulation of some protein kinase C isozymes in hair epithelial cells or inhibition of translocation of some protein kinase C isozymes to the membrane or cytoskeleton of hair epithelial cells.
Cyclosporin A is an immunosuppressive agent known to cause hirsutism. The mechanisms of action that cause hirsutism have not been fully elucidated, however. We have previously reported that several selective protein kinase C inhibitors promote the growth of murine hair epithelial cells and stimulate anagen induction. In this paper, we report on an investigation of the mechanisms of action of hairgrowing activity possessed by cyclosporin A from the viewpoint of whether it promotes hair epithelial cell growth or whether it modulates the expression or translocation of protein kinase C isozymes in hair epithelial cells. Our results indicate that cyclosporin A (over a wide dosage range of 1±1000 ng per ml) stimulates cultured murine hair epithelial cell growth to about 150%±160% relative to controls. We also observed growth-promoting effects on murine epidermal keratinocytes (about 140%) at the dose range of 1±100 ng per ml. At high dose ranges above 3 mg per ml, the growth of both cells was inhibited. On the other hand, we found that cyclosporin A reduces the overall expression of protein kinase C a, bI, and bII in cultured murine hair epithelial cells, and reduces the levels of protein kinase C a, bI, bII, and h in the particulate fraction from cultured murine hair epithelial cells. From these results, we speculate that the hair-growing activity of cyclosporin A is at least partially attributable to its growth-promoting in¯uence on hair epithelial cells sequential to its downregulation of some protein kinase C isozymes in hair epithelial cells or inhibition of translocation of some protein kinase C isozymes to the membrane or cytoskeleton of hair epithelial cells. Key words: baldness/hair follicles/hair growth/keratinocytes. J Invest Dermatol 117: 605±611, 2001 C yclosporin A is a highly lipophilic cyclic undecapeptide, produced by the fungus Trichoderma polysporum (Link ex Pers.) Rifai, Cylindrocarpon lucidum Booth, and Tolypocladium in¯atum Gams (Borel et al, 1976; Dreyfuss et al, 1976; Sta Èhelin, 1986) . It is known to possess a variety of biologic and physiologic actions such as antiparasitic, fungicidal, anti-in¯ammatory effects, and immunosuppressive properties. Up to now, it has been used in medical treatment as an immunosuppressant after organ transplantation and as a cure for several autoimmune disorders such as psoriasis, atopic dermatitis, Behc Ëet's disease, and myasthenia gravis. In addition, cyclosporin A is known to cause hirsutism as a side-effect (Laupacis, 1983; Harper et al, 1984; Wysocki and Daley, 1987) . Its hairgrowing effects have been examined by in vitro and in vivo experiments by several researchers. It has been shown that topical and intraperitoneal cyclosporin A administration induces anagen hair formation in C57BL-6 mice (Paus et al, 1989; and it has also been shown that oral (Sawada et al, 1987; Buhl et al, 1990) , topical, and subcutaneous (Watanabe et al, 1991) administration of cyclosporin A causes hair growth on nude mice. Moreover, its effects on male pattern baldness in humans have been investigated by several researchers (Picascia and Roenigk, 1987; Gilhar et al, 1990; Lutz, 1994) . The mechanisms of action of its hair-growing activity have not yet been fully described, however (Paus et al, 1996) . There are at present no data to support the hypothesis that cyclosporin A can directly stimulate hair epithelial cell proliferation. Only one piece of data exists that implies that cyclosporin A prolongs the anagen phase of the hair cycle, assumed from the fact that cyclosporin A prolongs the term of hair shaft growth in the hair follicle tissue organ culture system (Taylor et al, 1993) . On the other hand, it is reported that cyclosporin A has cytostatic effects on epidermal keratinocytes (Furue et al, 1988; Nickoloff et al, 1988) . In this report, we investigated the effect of cyclosporin A on cultured hair epithelial cell growth.
It has been reported that protein kinase C (PKC) acts as a negative hair-growing factor (Harmon et al, 1995; 1997; Xiong and Harmon, 1997; Takahashi et al, 2000) . In this report, we examine whether cyclosporin A, which possesses hair-growing effects, has an in¯uence on PKC expression or translocation in hair epithelial cells. PKC is a major signal transduction pathway in many tissues and cells, and is known to play a key role in cell differentiation and proliferation (Blobe et al, 1996) . The role of PKC in hair follicle tissue has not been elucidated, however. PKC was ®rst identi®ed and characterized by Nishizuka in 1977 as a serine threonine kinase (Nishizuka et al, 1978; Nishizuka, 1989) . Up to now, at least 12 isozymes have been isolated. PKC is now classi®ed into three major subgroups. The ®rst group is conventional PKC (a, bI, bII, and g), which is calcium-and diacylglycerol-dependent. The second group is novel PKC (d, e, h, and q) whose activity is calcium-independent but diacylglycerol-dependent. The third group is atypical PKC (z, l, i, and m) whose activity is calcium-and diacylglycerolindependent (Quest, 1996) . There is as yet limited information, however, on PKC isozyme expression in hair follicles. In human hair follicles, expression of PKC-a, PKC-b, PKC-d, and PKC-z has been con®rmed in cultured outer root sheath keratinocytes (Hoffmann et al, 1996) , and expression of PKC-a in mice (Wang and Smart, 1999) and PKC-h in humans (Koizumi et al, 1993; Wollina, 1997) has been con®rmed in outer root sheaths in immunohistochemical studies. We examined the expression and translocation of PKC-a, PKC-bI, PKC-bII, and PKC-h in cultured murine hair epithelial cells.
The mechanism of action by which cyclosporin A causes its immunosuppressive effects has been a major focus of research interest. Cyclosporin A is known to block activation of T cells by blocking interleukin-2 (IL-2) production (Buurman et al, 1986) . Up to now, as the targets of cyclosporin A, at least two routes have been proposed that lead to inhibition of IL-2 production. One is the cyclophilin±calcineurin±NFAT (nuclear factor of activated T cells) route. It has been elucidated that cyclosporin A binds to cyclophilin (cis±trans peptidyl±prolyl isomerase) (Fischer et al, 1989; Takahashi et al, 1989; Friedman and Weissman, 1991) , an intracellular receptor, and this complex binds to and inhibits the calcium-and calmodulin-dependent phosphatase calcineurin (Liu et al, 1991) , which is known to regulate the translocation of the transcription factor NFAT to the nucleus (Flanagan et al, 1991) , resulting in prevention of IL-2 gene transcription (Elliott et al, 1984; Granelli-Piperno et al, 1984; Kro Ènke et al, 1984) . Another hypothesis involves the phospholipid metabolism PKC route. Cyclosporin A has been shown to be associated with PKC isozyme induction in lymphocytes (Kimball et al, 1993) . Prevention of the activation of some PKC isozymes such as PKC-b is hypothesized as the mechanism by which cyclosporin A inhibits IL-2 synthesis and proliferation in stimulated human lymphocytes (Szamel et al, 1993) . We investigated the effect of cyclosporin A on the expression and translocation of PKC isozymes in hair epithelial cells.
In this report, we discuss the hypothesis that the hair-growing activity of cyclosporin A is related to its downregulation or inhibition of translocation of some PKC isozymes in hair epithelial cells.
MATERIALS AND METHODS
Materials Cyclosporin A was purchased from Sigma (St. Louis, MO). Antihuman rabbit polyclonal antibodies against PKC-a, PKC-bI, PKCbII, and PKC-h were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The second antibody used was biotinylated goat antirabbit immunoglobulins purchased from DAKO (Glostrup, Denmark). Streptavidin±horseradish peroxidase conjugate was purchased from Amersham Pharmacia Biotech (Little Chalfont, Buckinghamshire, U.K.).
Isolation and culturing of murine hair epithelial cells
Murine hair epithelial cells were isolated and cultured according to the method reported by Tanigaki et al (1990) with suitable modi®cations. The dorsal skin was peeled from 4-d-old C3H/HeNCrj mice (Charles River Japan, Kanagawa, Japan), cut into approximately 5 mm widths, washed three times with Eagle's minimum essential medium (MEM) containing 60 mg per liter of kanamycin and 10% fetal bovine serum (FBS), and then dipped into MEM containing 750 IU per ml of dispase (from Bacillus polymyxa; Godo Shusei, Tokyo, Japan), 60 mg per liter of kanamycin, and 10% FBS at 4°C for 20 h. After washing with Dulbecco's phosphate-buffered calcium-and magnesium-free saline (PBS) containing 50,000 U per liter of penicillin and 50 mg per liter of streptomycin (PBS±PS), the epidermis was peeled off and the remaining dermis layer was washed three times with PBS±PS and dispersed in Dulbecco's modi®ed Eagle's medium (DMEM) containing 0.25% collagenase (from Streptomyces parvulus; Nitta Gelatin, Osaka, Japan), 50,000 U per liter of penicillin, 50 mg per liter of streptomycin, 0.5% bovine serum albumin, and 20% FBS at 37°C for 1 h, stirring occasionally. This dermis suspension was ®ltered through a 212 mm nylon mesh, and the ®ltrate was centrifuged at 1400 rpm for 7 min. The pellet was then resuspended in PBS±PS. The suspension was left to stand for 15 min, allowing the hair follicle tissue to precipitate due to the difference in speci®c gravity, after which the supernatant was removed using an aspirator. The hair follicle tissue was resuspended in PBS±PS and then precipitated. This precipitation process was repeated three times. Finally, the hair follicle tissue was incubated in 0.05% ethylenediamine tetraacetic acid (EDTA)± 0.25% trypsin in Hanks' balanced calcium-and magnesium-free salt solution (HBSS) (Life Technologies, MD) at 37°C for 5 min. The hair follicle cells were suspended in DMEM supplemented with 50,000 U per liter of penicillin, 50 mg per liter of streptomycin, and 10% FBS at a density of 2 Q 10 5 cells per ml after ®ltration via a 212 mm nylon mesh. This hair follicle cell suspension was pipetted into a 24-well type I collagen-coated plate (2 cm 2 per well; Iwaki Glass, Chiba, Japan) at a rate of 1 ml per well (1 Q 10 5 cells per cm 2 ) and incubated in a humidi®ed atmosphere containing 5% CO 2 at 37°C for 24 h. After 24 h incubation, the medium was exchanged with MCDB153 (Sigma) (Boyce and Ham, 1983) containing 5 mg per liter of bovine insulin, 5 mg per liter of mouse epidermal growth factor, 40 mg per liter of bovine pituitary extract, 10 mg per liter of human transferrin, 0.4 mg per liter of hydrocortisone, 0.63 mg per liter of progesterone, 14 mg per liter of Ophosphorylethanolamine, 6.1 mg per liter of ethanolamine, 50,000 U per liter of penicillin, and 50 mg per liter of streptomycin after washing with PBS. It was then further incubated in a humidi®ed atmosphere containing 5% CO 2 at 37°C for 5 d. During incubation, the medium was removed and replaced with fresh medium every other day.
Isolation and culturing of mouse epidermal keratinocytes
The dorsal skin was peeled from 4-d-old C3H/HeNCrj mice (Charles River Japan), cut into approximately 5 mm widths, washed three times with MEM containing 60 mg per liter of kanamycin and 10% FBS, and then dipped into MEM containing 750 IU per ml of dispase (from Bacillus polymyxa; Godo Shusei), 60 mg per liter of kanamycin, and 10% FBS at 4°C for 20 h. After washing with PBS±PS, the epidermis was peeled off, washed ®ve times with PBS±PS, and then immersed in 0.05% EDTA± 0.25% trypsin in HBSS at 37°C for 10 min, stirring occasionally. After 10 min, DMEM (supplemented with 50,000 U per liter of penicillin, 50 mg per liter of streptomycin, and 10% FBS) was added, and the suspension was ®ltered through a 212 mm nylon mesh, followed by centrifugation at 1500 rpm for 5 min. The keratinocytes thus obtained were suspended in DMEM supplemented with 50,000 U per liter of penicillin, 50 mg per liter of streptomycin, and 10% FBS, pipetted into a 24-well type I collagen-coated plate (2 cm 2 per well; Iwaki Glass) at an initial cell density of 1 Q 10 5 cells per cm 2 , and incubated in a humidi®ed atmosphere containing 5% CO 2 at 37°C for 24 h. After 24 h incubation, the medium was exchanged with MCDB153 containing the same additives as those for the hair epithelial cells after washing with PBS. It was then further incubated in a humidi®ed atmosphere containing 5% CO 2 at 37°C for 5 d. During incubation, the medium was removed and replaced with fresh medium every other day.
Colorimetric assay for cell proliferation by MTT
The degree of cell growth was determined by means of an MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay (Carmichael et al, 1987) . MTT reagent (Sigma) was dissolved in PBS at a concentration of 5 mg per ml, ®ltered through a 0.45 mm membrane ®lter (cellulose acetate, DISMIC-13 cp; Advantec, Tokyo, Japan), and added 10% (vol/vol) to the culture medium. The culture plate was further incubated in a humidi®ed atmosphere containing 5% CO 2 at 37°C for 4 h. After removing the medium, the formed dye was extracted with acidic isopropanol containing 0.04 N HCl (adding 1.0 ml per 2 cm 2 well), and the absorbance was measured at 570 nm relative to 640 nm.
Immunoblot analysis (Western blotting)
Cultured hair epithelial cells were washed twice with PBS, treated for a few minutes with 0.05% trypsin (Sigma) dissolved in PBS, and, after addition of an equal amount of 0.06% trypsin inhibitor dissolved in PBS (from soybean, inhibiting activity of 1.4 mg of trypsin per 1.0 mg; Sigma), scraped, and centrifuged (1500 rpm, 5 min). The resultant cell pellet was sonicated in ®ve 10 s bursts in Buffer A [20 mM Tris(hydroxymethyl)aminomethane (Tris) HCl (pH 7.5), 2 mM EDTA, 10 mM ethyleneglycol-bis(baminoethyl ether)-N,N,N¢,N¢-tetraacetic acid, 0.25 M sucrose, 2 mM phenylmethylsulfonyl¯uoride, 10 mg per ml leupeptin, and 10 mM 2-mercaptoethanol, ®nal concentrations] and centrifuged at 100,000 Q g for 60 min (4°C). The supernatants were concentrated to 1/10 volume using an ultra®lter (M.W. 30,000 cutting, UFP2 TTK; Millipore, MA) and stored as the cytosol fraction at ±80°C. The pellets were then dissolved in Buffer B [Buffer A + 0.5% (wt/vol) polyoxyethylene (10) octylphenyl ether (Triton X-100)], sonicated in ®ve 10 s bursts, and centrifuged at 100,000 Q g for 60 min (4°C). The supernatants were concentrated to 1/10 volume using an ultra®lter (M.W. 30,000 cutting, UFP2 TTK; Millipore) and stored as the particulate fraction at ±80°C. Protein concentrations were determined spectrophotometrically using a DC-Protein Assay kit (Bio-Rad, CA).
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was performed according to the method of Laemmli (1970) . Aliquots (10 mg of protein per lane) of the cytosol or particulate fractions were mixed with sample buffer (0.125 M Tris-HCl (pH 6.8), 2% (wt/ vol) SDS, 10% (wt/vol) glycerol, and 5% (vol/vol) 2-mercaptoethanol, ®nal concentrations), heated at 98°C for 3 min, and subjected to SDS-PAGE using 7.5% polyacrylamide gel (Pagel NPU-7.5; Atto, Tokyo, Japan). Protein standards for molecular weight were as follows: phosphorylase B, 97.4 kDa; bovine serum albumin, 68.0 kDa; ovalbumin, 46.0 kDa; carbonic anhydrase, 31.0 kDa; trypsin inhibitor, 20.1 kDa; lysozyme, 14.4 kDa (ECL protein molecular weight markers, Amersham Pharmacia Biotech). The proteins were electro-blotted onto a nitrocellulose membrane (Schleicher & Schuell, Keene, NH) using a submarine transfer apparatus (Trans-Blot Cell, Bio-Rad) for 3 h at 60 V/320 cm 2 (Towbin et al, 1979) . The transfer buffer conditions were as follows: 25 mM Tris-HCl (pH 8.3), 192 mM glycine, and 20% (vol/vol) methanol. The blocking was performed on a rocking platform in a solution containing 5% bovine serum albumin and 0.1% (wt/vol) polyoxyethylene (20) sorbitan monolaurate (Tween 20) in PBS (PBS-T) for 1 h at room temperature, and the membranes were then washed with PBS-T for 5 min (three times). Next, the membranes were incubated overnight at 4°C with diluted polyclonal antibodies (antihuman rabbit antibodies, Q500 dilution by the blocking solution) against PKC isozymes (a, bI, bII, and h). The membranes were then washed with PBS-T, incubated with biotinylated goat antirabbit immunoglobulins (Q3000 dilution by PBS-T) for 1 h at room temperature, and washed with PBS-T. Next, the membranes were incubated with streptavidin± horseradish peroxidase conjugate (Q1000 dilution with PBS-T) for 1 h at room temperature and then washed with PBS-T. Detection of immunoreactive protein was achieved by chemiluminescence using the ECL Western blotting detection system (Amersham Pharmacia Biotech) and exposed to X-ray ®lm (RX-U, Fuji Photo Film, Tokyo, Japan). Protein bands were identi®ed as PKC by their molecular weight, comigration with their standard proteins (PKC-a, PKC-bI, PKC-bII, and PKC-h; human recombinant; Calbiochem-Novabiochem, CA), and lack of staining by the secondary antibody when the primary antibody was omitted. Quantitative analysis of PKC isozyme expression was performed by densitometry (CS-9000; Shimadzu, Kyoto, Japan).
RESULTS
Cyclosporin A promotes the growth of both hair epithelial cells and epidermal keratinocytes at the optimum concentration It is reported that cyclosporin A inhibits the growth of epidermal keratinocytes (Furue et al, 1988; . We compared the effects of cyclosporin A on epidermal keratinocyte and hair epithelial cell growth. Our results con®rmed that cyclosporin A promotes cultured murine hair epithelial cell growth at about 150%±160% relative to controls over the wide concentration range of 1±1000 ng per ml. At a high dose of 3 mg per ml of cyclosporin A, hair epithelial cell growth was partially inhibited; and hair epithelial cell growth was completely inhibited above a cyclosporin A concentration of 10 mg per ml (Fig 1) . We observed morphologic changes, such as elongation and vacuolization, in hair epithelial cells incubated in 3 mg per ml of cyclosporin A (Fig 2c) . We also con®rmed that cyclosporin A promotes murine epidermal keratinocyte growth at about 140% relative to controls over the wide concentration range of 1±100 ng per ml and partially inhibits the growth of epidermal keratinocytes at concentrations of 1±3 mg per ml. Epidermal keratinocyte growth was completely inhibited above a cyclosporin A concentration of 10 mg per ml (Fig 3) . We observed morphologic changes, such as enlargement and vacuolization, in epidermal keratinocytes incubated with 3 mg per ml of cyclosporin A (Fig 2e) .
Cyclosporin A dramatically decreases the levels of PKC-a, PKC-bI, PKC-bII, and PKC-h in the particulate fraction of cultured hair epithelial cells We examined the effect of cyclosporin A on the expression of PKC isozymes in cultured murine hair epithelial cells using Western blotting. The hair epithelial cells were incubated with 0.1 mg per ml and 1.0 mg per ml of cyclosporin A for the ®nal 48 h of the 5 d culture period. The doses of cyclosporin A for the investigation of PKC protein levels were set at 1.0 mg per ml, at which hair epithelial cells show maximum growth-promoting activity, and its 10% concentration, i.e., 0.1 mg per ml.
We observed signi®cant decreases in the overall expression of PKC-a, PKC-bI, and PKC-bII in hair epithelial cells cultured in media containing 0.1 mg per ml or 1.0 mg per ml of cyclosporin A (c 2 test for independence; p < 0.001 for PKC-a, PKC-bI, and PKC-bII); the rate of decrease at 1.0 mg per ml was higher than that at 0.1 mg per ml in all these cases; conversely, the overall expression of PKC-h in hair epithelial cells cultured in media containing 0.1 mg per ml and 1.0 mg per ml of cyclosporin A both increased about 1.5-fold relative to the controls. . Cyclosporin A dramatically decreases the levels of PKC-a, PKC-bI, PKC-bII, and PKC-h in the particulate fraction of cultured murine hair epithelial cells. Western blotting analysis is shown for PKC-a, PKC-bI, PKC-bII, and PKC-h in cytosol and particulate fractions extracted from cultured murine hair epithelial cells. Cyclosporin A (0.1 mg per ml and 1.0 mg per ml) was added to the culture medium during the ®nal 48 h of the 5 d culture period. Cyclosporin A dissolved in methanol was added in a volume of 1/100 to the culture medium. For the control, we used a medium to which an amount of 1/100 volume of methanol was added. The data show the cytosol fraction of the control (lane 1), the cytosol fraction of 0.1 mg per ml cyclosporin A (lane 2), the cytosol fraction of 1.0 mg per ml cyclosporin A (lane 3), the particulate fraction of the control (lane 4), the particulate fraction of 0.1 mg per ml cyclosporin A (lane 5), and the particulate fraction of 1.0 mg per ml cyclosporin A (lane 6). Speci®c immunoreactive 80 kDa bands for PKC-a, PKC-bI, PKC-bII, and PKC-h were detected. These results were con®rmed in an additional experiment. We observed signi®cant decreases in the levels of PKC-a, PKCbI, PKC-bII, and PKC-h in the particulate fraction of hair epithelial cells cultured in media containing 0.1 mg per ml or 1.0 mg per ml of cyclosporin A (c 2 test for independence; p < 0.001 for PKC-a, PKC-bI, PKC-bII, and PKC-h). The rate of decrease at 1.0 mg per ml was higher than that at 0.1 mg per ml in all these cases.
As a result of the addition of 0.1 mg per ml of cyclosporin A, the level of PKC-bI in the cytosol fraction of hair epithelial cells decreased. As a result of the addition of 1.0 mg per ml cyclosporin A, the levels of PKC-a, PKC-bI, and PKC-bII in the cytosol fraction of hair epithelial cells decreased. Addition of 0.1 mg per ml and 1.0 mg per ml cyclosporin A led to increased levels of PKC-h in the cytosol fraction of hair epithelial cells (Figs 4, 5) .
DISCUSSION
Reports of the effects of cyclosporin A describe its growthinhibiting action on normal human epidermal keratinocytes and on murine epidermal keratinocytes and keratinocyte cell lines (Furue et al, 1988) ; and the G 1 arrest of the cell cycle has been inferred as being the mechanism of the proliferative inhibition of keratinocytes by cyclosporin A (Khandke et al, 1991) . We observed growth-promoting action on hair epithelial cells by cyclosporin A of about 150%±160% relative to the controls at the optimum dose range of 1±1000 ng per ml, however; at the same time, growth-promoting action on epidermal keratinocytes (about 140% relative to the controls) was observed at the dose range of 1±100 ng per ml, although the effect was relatively weaker than that on the hair epithelial cells. In both cases, a growth-inhibiting effect was observed at a high dose range (over the 3 mg per ml range), which is consistent with previous reports (Furue et al, 1988; Nickoloff et al, 1988; Khandke et al, 1991) . Morphologic changes triggered by cyclosporin A such as vacuolization were reported in the A431 human squamous cell carcinoma cell line (Furue et al, 1988) and in normal human keratinocytes incubated with 10 mg per ml of cyclosporin A. We also observed morphologic changes both in epidermal keratinocytes and in hair epithelial cells at 3 mg per ml of cyclosporin A; at a cyclosporin A level of 10 mg per ml, all the cells died, in the case of both epidermal keratinocytes and hair epithelial cells. Consequently, in both the epidermal keratinocytes and hair epithelial cells, growth-promoting action by cyclosporin A was observed at the speci®c common dose range of 1±100 ng per ml. Concerning the similarity of the effects on growth of both epidermal keratinocytes and hair epithelial cells induced by this compound, this is a predictable result because both types of cells are of the same origin from the viewpoint of the genesis of the epidermis and hair. Slight differences exist, however, between the two types of cells in their response to cyclosporin A. In clinical treatments using cyclosporin A, the blood level of cyclosporin A is closely controlled by a doctor in the range of 80±220 ng per ml so as not to cause any side-effects (Uchida et al, 1988) . In psoriatic patients under cyclosporin A treatment, its concentration in wet epidermis was calculated by Fisher et al (1988) to be 1±3 mg per ml. Although it cannot be stated that the concentration of cyclosporin A in a cultured medium directly corresponds to the blood level or tissue level in vivo, it is logical to infer that the same substance causes hirsutism and cures psoriasis, if we compare the effects of cyclosporin A on the hair epithelial cells and epidermal keratinocytes at the cyclosporin A concentration level of 1 mg per ml in a medium. More speci®cally, at the cyclosporin A concentration level of 1 mg per ml in a medium, the growth of hair epithelial cells is improved, whereas no growth-promoting effect is observed in epidermal keratinocytes. We suggest that the difference in growth curves between the two types of cells when responding to the same dose of cyclosporin A holds the key to understanding the pharmacologic effects of cyclosporin A.
It has been reported that PKC acts as a negative hair-growing factor (Harmon et al, 1995 Xiong and Harmon, 1997) . Li et al examined the levels of PKC-a and PKC-d in BALB/c mice back skin in the course of hair growth induced by diphencyprone (Li et al, 1999a) and hair plucking (Li et al, 1999b) , and concluded that the downregulation of PKC-a expression in skin appears to cause anagen induction in the hair cycle progression. Takahashi et al (1999) reported that procyanidin oligomers selectively and intensively promote murine hair epithelial cell growth in vitro and stimulate anagen induction in vivo. It is speculated that the hairgrowing activity of procyanidins is linked to their PKC inhibitory activity based on the fact that several other selective PKC inhibitors also exhibit hair-growing activity (Takahashi et al, 2000) .
Cyclosporin A is known to block the activation of T cells by blocking IL-2 production (Buurman et al, 1986) . One of several recognized views is that the target of cyclosporin A in signal transduction, which causes inhibition of IL-2 production, is the cyclophilin±calcineurin±NFAT route. On the other hand, a phospholipid metabolism±PKC signal transduction route has also been suggested (Szamel et al, 1993) as the target of cyclosporin A. As for the enzymatic inhibition of PKC by cyclosporin A, there are both positive and negative reports. Walker et al (1989) reported that cyclosporin A inhibits the PKC in renal tubular epithelial cells in an in vitro enzyme assay system using the cytosol fraction of the cell. On the other hand, Wenzel-Seifert et al (1994) reported that cyclosporin A did not directly inhibit recombinant PKC isozymes (a, bI, g, d, e, and z) or PKC puri®ed from rat brain (a, bI, bII, and g). Besides the direct inhibition of PKC enzymatic activity, Gupta et al (1992) reported the effect of downregulation of PKC-a and PKC-b expression by cyclosporin A in human lymphocytes. Szamel et al (1993) reported that cyclosporin A speci®cally inhibits the activation and translocation of PKC-b to the plasma membrane in human lymphocytes, and demonstrated that this is caused by inhibiting the activation of lysophosphatid acyltransferase-catalyzed elevated incorporation of cis-polyunsaturated fatty acids into plasma membrane phospholipids that is necessary for the activation of PKC (Sekiguchi et al, 1988; Asaoka et al, 1992) . Kimball et al (1993) pointed out that cyclosporin A inhibits induction of the``activator of DNA replication'' (ADR) activated by PKC in a cell-free assay system. Hassan et al (1997) examined in human lymphocytes the relation of PKC-b activation and intracellular accumulation of IL-2, which is inhibited by cyclosporin A, and concluded that activation of PKC-b is critical for IL-2 accumulation and that the target of cyclosporin A lies between the membrane signal and PKC.
We have examined for the ®rst time the effect of cyclosporin A on PKC expression and translocation in murine hair epithelial cells. Our results indicate that cyclosporin A inhibits the overall expression of PKC-a, PKC-bI, and PKC-bII, and that cyclosporin A increases the overall expression of PKC-h in cultured murine hair epithelial cells. Moreover, we clari®ed that cyclosporin A decreases the levels of PKC-a, PKC-bI, PKC-bII, and PKC-h in the particulate fraction of cultured murine hair epithelial cells. It is known that PKC distribution undergoes changes during cell activation. For example, PKC-a, PKC-bII (human promyelocytic leukemia cell line HL60) (Hocevar and Fields, 1991) , and PKC-h (RAW 264.7 macrophages) (Chen et al, 1997) are known to translocate to the plasma membrane in response to phorbol ester stimulation. PKC-bI and PKC-bII are known to translocate to the membrane fraction and cytoskeletal fraction after phorbol ester treatment in human megakaryoblastic leukemia cell line MEG-01 (Nagata et al, 1996) . The accumulation of PKC-a in the endoplasmic reticulum, the translocation of PKC-bI to the ruf¯ed membrane edges, and the association of PKC-bII with actin-rich micro®laments of the cytoskeleton are known to increase as results of phorbol ester stimulation in PKC isozyme overexpressing NIH 3T3 ®broblasts (Goodnight et al, 1995) . PKC-h is reported to be present in the rough endoplasmic reticulum and outer nuclear membrane in normal human keratinocytes (Chida et al, 1994) . It is considered that cyclosporin A affects intracellular localization of at least these four PKC isozymes (a, bI, bII, and h) and modulates interactions with membranes, the cytoskeleton, or with distinct subcellular compartments, followed by initiation of cellular reac- VOL. 117, NO. 3 SEPTEMBER 2001 tions such as mitogenesis and differentiation or speci®c cellular responses such as changes in speci®c gene expression or changes in secretion of growth factors, cytokines, or other cellular factors.
Experiments using ascomycin and rapamycin have shown that inhibition of cyclophilin and calcineurin is not required for new hair growth (Iwabuchi et al, 1995) . Our results demonstrate for the ®rst time that cyclosporin A can stimulate hair epithelial cell proliferation in cell culture systems at the optimum concentration. We also found that cyclosporin A causes modulation in the expression and translocation of PKC isozymes (a, bI, bII, and h) in hair epithelial cells. Our results, combined with those of other investigations, suggest a possible link between hair-growing activity and PKC downregulation (a, bI, and bII) or inhibition of translocation (a, bI, bII, and h) of some PKC isozymes by cyclosporin A. Further investigations of other PKC isozymes will provide useful information about whether selective PKC isozyme expression is involved in the regulation of hair epithelial cell proliferation, differentiation, and hair cycle regulation.
